2 ex-CEOs of Washington biotech company face 20 years after fraud convictions [Yahoo! Finance]
CYTODYN INC (CYDY)
NASDAQ:AMEX Investor Relations:
ir.cytodyn.com
Company Research
Source: Yahoo! Finance
securities fraud scheme related to HIV and COVID-19 drugs, the U.S. Justice Department announced Tuesday. The jury on Monday ruled that Nader Pourhassan, 61, of Lake Oswego, Ore., along with his counterpart 71-year old Kazem Kazempour of Potomac, Md., engaged in a scheme to lie to investors about development of an experimental drug in order to artificially inflate and maintain the price of its stock so as to attract new investors for CytoDyn Inc., a publicly traded biotechnology company based in Vancouver, Wash. "The defendants lied to investors and the public -- including during the height of the COVID-19 pandemic -- about a drug that purportedly treated HIV and COVID-19 in order to artificially inflate CytoDyn's stock price," Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of DOJ's criminal division, wrote Tuesday in a release The men are scheduled to be sentenced by a federal judge at a later date and face a maximum penalty of 20 years in prison for eac
Show less
Read more
Impact Snapshot
Event Time:
CYDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYDY alerts
High impacting CYTODYN INC news events
Weekly update
A roundup of the hottest topics
CYDY
News
- December 2024 Letter to Shareholders [Yahoo! Finance]Yahoo! Finance
- December 2024 Letter to ShareholdersGlobeNewswire
- CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology [Yahoo! Finance]Yahoo! Finance
- CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in OncologyGlobeNewswire
- CytoDyn Phase 2 study of leronlimab cleared by FDA [Seeking Alpha]Seeking Alpha
CYDY
Sec Filings
- 11/22/24 - Form 8-K
- 10/30/24 - Form 4
- 10/30/24 - Form 4
- CYDY's page on the SEC website